Regenxbio Inc (RGNX)
16.04
+0.14
(+0.88%)
USD |
NASDAQ |
Apr 24, 16:00
16.05
+0.01
(+0.06%)
After-Hours: 20:00
Regenxbio Shares Outstanding: 48.99M for March 11, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
March 11, 2024 | 48.99M |
February 22, 2024 | 44.43M |
December 31, 2023 | 44.05M |
November 02, 2023 | 43.99M |
September 30, 2023 | 43.99M |
August 30, 2023 | 43.96M |
July 27, 2023 | 43.96M |
July 07, 2023 | 43.88M |
June 30, 2023 | 43.62M |
April 27, 2023 | 43.47M |
April 03, 2023 | 43.47M |
March 31, 2023 | 43.46M |
February 23, 2023 | 43.46M |
December 31, 2022 | 43.30M |
October 27, 2022 | 43.29M |
September 30, 2022 | 43.29M |
July 27, 2022 | 43.23M |
June 30, 2022 | 43.17M |
April 28, 2022 | 43.13M |
April 04, 2022 | 42.99M |
March 31, 2022 | 42.98M |
February 24, 2022 | 42.95M |
December 31, 2021 | 42.83M |
October 28, 2021 | 42.77M |
September 30, 2021 | 42.75M |
Date | Value |
---|---|
August 04, 2021 | 42.60M |
June 30, 2021 | 42.56M |
April 30, 2021 | 42.51M |
April 05, 2021 | 42.51M |
March 31, 2021 | 42.50M |
February 25, 2021 | 42.50M |
January 12, 2021 | 42.38M |
December 31, 2020 | 37.48M |
October 30, 2020 | 37.41M |
September 30, 2020 | 37.40M |
July 31, 2020 | 37.33M |
June 30, 2020 | 37.29M |
May 01, 2020 | 37.24M |
March 31, 2020 | 37.19M |
March 30, 2020 | 37.19M |
February 21, 2020 | 37.14M |
December 31, 2019 | 36.99M |
November 01, 2019 | 36.87M |
September 30, 2019 | 36.84M |
August 02, 2019 | 36.81M |
June 30, 2019 | 36.75M |
May 03, 2019 | 36.64M |
April 01, 2019 | 36.61M |
March 31, 2019 | 36.61M |
February 22, 2019 | 36.42M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
36.64M
Minimum
May 03 2019
48.99M
Maximum
Mar 11 2024
41.39M
Average
42.77M
Median
Oct 28 2021
Shares Outstanding Benchmarks
Sarepta Therapeutics Inc | 93.86M |
Amgen Inc | 535.92M |
Gilead Sciences Inc | 1.246B |
AbbVie Inc | 1.766B |
Bristol-Myers Squibb Co | 2.022B |